ArticleAbdominal radiology (New York)2026
Ki-67 expression correlates with hepatocellular carcinoma recurrence and is predictable using radiomics features.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aims to identify the optimal Ki-67 cutoff for predicting HCC recurrence and to develop a radiomics model based on CT arterial phase features for non-invasive preoperative Ki-67 assessment.
methodsA total of 180 HCC patients who underwent radical resection were enrolled. The prognostic value of Ki-67 was analyzed using multivariate Cox proportional hazards regression models, and the optimal Ki-67 expression threshold for recurrence prediction was determined by the area under the ROC curve (AUC).Radiomics features from both intratumoral and peritumoral regions were extracted from preoperative CT arterial-phase images. Key features were selected to develop a radiomics prediction model.The predictive performances of the radiomics, clinical, and combined models were compared, and key influencing features for the optimal model were identified through Shapley additive explanations (SHAP) analysis.
resultsHigh Ki-67 expression (≥ 25%) was identified as an independent risk factor for postoperative HCC recurrence (hazard ratio [HR] = 9.923, 95% confidence interval [CI]: 3.383-29.108, P < 0.001). The recurrence-free survival rate was significantly lower in the high Ki-67 expression group compared to the low expression group (P = 0.009). In the testing set, the radiomics model utilizing random forest (RF) algorithm demonstrated superior predictive performance for Ki-67 expression (AUC = 0.869, sensitivity = 0.733, specificity = 0.846). Its performance significantly exceeded that of the clinical model (AUC: 0.869 vs. 0.540, P = 0.005), while the combined model showed no significant improvement compared to the radiomics model alone (AUC: 0.870 vs. 0.869, P = 0.979). SHAP analysis revealed that the peritumoral texture heterogeneity feature (peri_wavelet_LLH_firstorder_Kurtosis) contributed most significantly to the radiomics model (SHAP value = + 0.17).
conclusionHigh Ki-67 expression (≥ 25%) is a key prognostic factor for postoperative HCC recurrence. The CT arterial phase radiomics model allows non-invasive preoperative Ki-67 assessment, emphasizing the role of peritumoral heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.